Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)

Clinical trial NCT04484415 · UNKNOWN

Trial details

NCT number: NCT04484415
Sponsor: Asieris MediTech (Hong Kong) Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Grade 2/3

Start date: 2020-11-10
Primary completion: 2023-12-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.